kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am J Physiol Renal Physiol 295: F1535-F1544, 2008. First published September 10, 2008 doi:10.1152/ajprenal.90445.2008.-Homozygous mice carrying kd (kidney disease) mutations in the gene encoding prenyl diphosphate synthase subunit 2 (Pdss2 kd/kd ) develop interstitial nephritis and eventually die from end-stage renal disease. The PDSS2 polypeptide in concert with PDSS1 synthesizes the polyisoprenyl tail of coenzyme Q (Q or ubiquinone), a lipid quinone required for mitochondrial respiratory electron transport. We have shown that a deficiency in Q content is evident in Pdss2 kd/kd mouse kidney lipid extracts by 40 days of age and thus precedes the onset of proteinuria and kidney disease by several weeks. The presence of the kd (V117M) mutation in PDSS2 does not prevent its association with PDSS1. However, heterologous expression of the kd mutant form of PDSS2 together with PDSS1 in Escherichia coli recapitulates the Q deficiency observed in the Pdss2 kd/kd mouse. Dietary supplementation with Q10 provides a dramatic rescue of both proteinuria and interstitial nephritis in the Pdss2 kd/kd mutant mice. The results presented suggest that Q may be acting as a potent lipid-soluble antioxidant, rather than by boosting kidney mitochondrial respiration. Such Q10 supplementation may have profound and beneficial effects in treatment of certain forms of focal segmental glomerulosclerosis that mirror the renal disease of the Pdss2 kd/kd mouse.
ubiquinone; mitochondrial lipid metabolism; genetic renal disease; focal segmental glomerulosclerosis; antioxidant COENZYME Q (Q or ubiquinone) is an essential factor of aerobic respiration and oxidative phosphorylation. Q also functions as a lipid-soluble antioxidant in cellular biomembranes and scavenges reactive oxygen species (4, 7). Yeast strains not able to produce Q show sensitivity to oxidative stresses such as hydrogen peroxide and autooxidized polyunsaturated fatty acids (10, 44) . Q is a dietary supplement and is also used in therapeutic treatments for neurodegenerative and cardiovascular diseases and for statin-induced symptoms of Q deficiency (11, 35) .
Q is composed of a benzoquinone ring with a polyisoprenoid side chain of varying length. Living organisms possess distinct isoforms of Q depending on the length of the isoprenoid side chain (17) . For example, humans produce Q 10 , mice produce predominantly Q 9 and small amounts of Q 10 , Saccharomyces cerevisiae produce Q 6 , and Escherichia coli produce Q 8 . The difference in the tail length of Q is determined by the longchain polyprenyl diphosphate synthase in each organism (30) . Long-chain trans-prenyl diphosphate synthases catalyze the condensation step for the isoprenoid tails from farnesyl diphosphate (C15) or geranylgeranyl diphosphate (C20) and isopentenyl diphosphate (C5). Structural analyses and site-directed mutagenesis have shown that short-and long-chain polyprenyl diphosphate synthases contain seven conserved regions designated as domains I through VII (Fig. 1A) and two aspartate-rich motifs (DDXXD) that are substrate binding sites in association with Mg 2ϩ (12, 18, 28, 29, 45) . These analyses suggest that amino acid residues at the fourth and fifth positions before the aspartate-rich motif in domain II and two amino acid residues in domain II have an important role in determining the length of the isoprenoid tails.
Polyprenyl diphosphate synthases are classified into two types of homo-or heterocomplexes. Most of the short polyprenyl diphosphate synthases (C10 -C25) in both prokaryotes and eukaryotes are homodimers (27) . In contrast, long-chain (C30 -C50) polyprenyl diphosphate synthases are more diversified. In E. coli, octaprenyl diphosphate synthase forms a homodimer necessary for synthesis of the octaprenyl diphosphate tail for both Q and menaquinone (16) , whereas the enzymes that supply hexa-and heptaprenyl diphosphate for menaquinone in the genus Micrococcus and Bacillus are heterodimers (47) . The Coq1 polypeptide in S. cerevisiae functions on its own to produce hexaprenyl diphosphate; however, when expressed in fission yeast, Schizosaccharomyces pombe, it functions as a partner protein to produce decaprenyl diphosphate (49) . In S. pombe, mice, and humans, long-chain prenyl diphosphate synthases are composed of two subunits (PDSS1/ Dps1 and PDSS2/Dlp1) and form heterotetramers (39, 40) . PDSS2/Dlp1, which is subunit 2 of nonaprenyl or decaprenyl diphosphate synthase in fission yeast and mammals, possesses the conserved domains of a prenyl diphosphate synthase. However, the subunit 2 lacks aspartate-rich motifs in domains II and VI (39, 40) . PDSS2 orthologs also are found in Drosophila, Xenopus, and mammals. Therefore, the heterotetramer conformation of long-chain prenyl diphosphate synthases might be standard in higher eukaryotes.
Recently, several diagnostic examples of inherited Q deficiency, caused by mutations in Pdss1, Pdss2, human COQ2 (hCOQ2), or CABC1/COQ8 have been reported (8, 19, 23, 25, 26, 36) . These patients have severe Q 10 deficiency and severe mitochondrial disease phenotypes such as encephalomyopathy, ataxia, renal diseases, cerebellar atrophy, and hyperlactatemia. Oxidative phosphorylation activities in fibroblasts (19, 23, 25, 26) , muscle extracts (9, 23), or muscle mitochondria (25) from these patients harboring a point mutation on Pdss1, Pdss2, hCOQ2, or CABC1/COQ8 are significantly lower than in samples from healthy individuals. Addition of either decylubiquinone or Q 2 , two soluble Q analogs, restored oxidative phosphorylation activity in cultured skin fibroblasts (19, 26) and muscle extracts (23) of the affected patients. Therefore, the respiratory deficiency and the symptoms in the patients are attributed to primary Q deficiency. In some cases, prolonged Q supplementation relieves the symptoms caused by Q deficiency (37) . The reasons for the different responses to Q supplementation are still unclear.
In this study we have examined the nature of the Q deficiency in the Pdss2 kd/kd mouse, which harbors a V117M mutation in PDSS2 and develops kidney disease in early adulthood (33, 34) . The V117 residue is invariant in PDSS2 polypeptides from fission yeast to humans (39) . Based on immunohistochemical profiling and electron microscopy, the phenotype of the Pdss2 kd/kd mouse resembles the collapsing glomerulopathy variant of focal segmental glomerulosclerosis (3) . We have shown that a deficiency in Q content is evident in kidney lipid extracts by 40 days of age and that dietary supplementation with Q provides a dramatic rescue of the proteinuria and interstitial nephritis. The results suggest that if human renal patients are identified who have PDSS2 mutations similar to that of the Pdss2 kd/kd mouse, Q supplementation may have profound and beneficial effects.
MATERIALS AND METHODS
Mice. All animal studies have been approved by the University of California, Los Angeles (UCLA) and University of Pennsylvania institutional review boards. Mice harboring the Pdss2 kd/kd Fig. 1 . Amino acid sequence alignment of mouse nonaprenyl diphosphate synthase subunit 1 (PDSS1/mSPS1) and subunit 2 (PDSS2/ mDLP1) isoforms. A: typical long-chain polyisoprenyl diphosphate synthases, such as PDSS1 and PDSS2-L, have conserved domains I through VII. An arrow shows the location of the kd/kd mutation V117M within conserved domain I. B: alternative splicing produces PDSS2-Short (PDSS2-S) containing exons 1-3b and PDSS2-Long (PDSS2-L) containing exons 1-3a and 4 -8. PDSS2-S contains only domains I through III. The predicted polypeptide produced from the Pdss2 BAC clone 256E1 is also shown. One transgenic line of B6.kd/kd mice harboring an insertion of this BAC clone 256E1 exhibits sporadic rescue from kidney disease. missense mutation (V117M) on the B6 genetic background, line G transgenic mice expressing a truncated form of Pdss2, and B6.Alb/ cre,Pdss2 loxP/loxP mice, in which the Pdss2 gene is knocked out in hepatocytes, have been described previously (14, 33, 34) . Assays of urine albumin were performed with ELISA kits from Bethyl Laboratories as described previously (33) . When the mice were euthanized, hematoxylin and eosin (H&E)-stained sections of the kidneys were prepared. The sections were examined blindly and scored as follows: 0, no tubular dilatation and no mononuclear cell infiltrates; 1, small focal areas of cellular infiltration and tubular dilatation involving Ͻ10% of the cortex; 2, involvement of up to 25% of the cortex; 3, involvement of up to 50% of the cortex; 4, extensive damage involving Ͼ75% of the cortex.
Preparation of mouse kidney and liver homogenates. Whole kidneys and lobes of livers were dissected from euthanized mice and stored at Ϫ80°C until homogenization. Samples were homogenized in 5 ml of 1ϫ PBS, pH 7.4 (137 mM NaCl, 8 mM Na 2HPO4, 2.7 mM KCl, and 1.5 mM KH 2PO4) at 4°C, with a total of 10 strokes with a tight-fitting Teflon pestle rotating at maximal speed with a Fisher Scientific Lab Stirrer LR400A. The homogenate was centrifuged at 1,000 g for 5 min, supernatants were removed to fresh vials, and protein concentrations were measured using the bicinchoninic acid assay (Pierce, Rockford, IL). Aliquots of each homogenate were transferred to 50-ml glass tubes and stored at Ϫ80°C until extracted.
Q 10 supplementation. Mice were provided Q10 supplements (Tishcon LiQsorb, 100 mg/ml) in their drinking water. In a pilot experiment, three males and two females were given 100 mg Q10/400 ml water (0.25 mg/ml), beginning at 47 days of age. While on this dose, both females had litters. After weaning, the progeny received 0.50 mg Q10/ml water. Mice consumed ϳ12-16 ml of water per day; thus at this dose, the mice received ϳ200 mg Q10 ⅐ kg body wt Ϫ1 ⅐ day Ϫ1 . Some of their offspring were given a dose of 400 ⅐ kg body wt Ϫ1 ⅐ day Ϫ1 , beginning at the time they were weaned. Expression of murine PDSS1 and PDSS2 prenyl diphosphate synthase subunits in E. coli. E. coli strain DH5␣ was used for general plasmid construction and protein expression (42) . E. coli cells were grown in Luria Bertani (LB) medium with appropriate antibiotics such as 100 g/ml carbenicillin, 100 g/ml ampicillin, and 50 g/ml kanamycin. The pGEX-KG (GE Healthcare Bio-Sciences, Piscataway, NJ) and pET-28c (Novagen, Madison, WI) plasmids served as vectors.
cDNAs prepared from either B6 or B6.Pdss2 kd/kd liver (34) were used as template DNA to PCR amplify the short and long isoforms of Pdss2. The 0.8-kb amplicon containing the Pdss2-Short isoform cDNA was generated with B6 liver cDNA as template and two oligonucleotide primers, 5-EcoRI-mDLP1 5Ј-CCGAATTCGAAT-GAGCTCCGGCAG-3Ј (creates an EcoRI site) and 3-SalI-mDLP1-Short, 5Ј-ACGCGTCGACTTACTTCATGTTGTCACTGCC-3Ј (creates a SalI site). The amplified 0.8-kb fragment was digested with EcoRI and SalI enzymes and inserted into the same sites of pET28c to yield pET28c-PDSS2-S. The pET28c-PDSS2-S plasmid was digested with XbaI and SalI, and the resulting fragment was cloned into the same sites of pGEX-mSPS1 (39) to construct pM12S. Glutathione S-transferase (GST)-tagged-PDSS1 and His6-tagged-PDSS2-Short are coexpressed from the Tac promoter of pM12S.
A similar scheme was used to generate pM12L and pM12Lkd. The 1.2-kb amplicon containing the Pdss2-Long isoform cDNA was generated with B6 liver cDNA as template and the oligonucleotide primers, 3-SalI-mDLP1-L, 5Ј-ACGCGTCGACTCAAGAAAATCT-GGTCACAGC-3Ј (creates a SalI site) and 5-EcoRI-mDLP1. The amplified 1.2-kb fragment was digested with EcoRI and SalI enzymes and inserted into the same sites of pET28c to yield pET28c-PDSS2-L. The pET28c-PDSS2-L plasmid was digested with XbaI and SalI, and the resulting fragment was cloned into the same sites of pGEXmSPS1 to construct pM12L. The same sequence of steps was used to construct pM12Lkd, except that cDNA prepared from B6.Pdss2 kd/kd mouse liver was used as template DNA. pM12L and pM12Lkd drive expression of GST-tagged-PDSS1 and either His 6-tagged-PDSS2-Long form or His 6-tagged-PDSS2-Long form harboring the kd missense mutation (V117M).
DH5␣ harboring pM12S, pM12LB6, pM12Lkd, or the empty vector pGEX-KG were inoculated in 5 ml of LB medium with ampicillin and cultured at 30°C, 250 rpm, for 18 h. Aliquots of each bacterial culture (500 l) were used to inoculate 50 ml of fresh LB medium with carbenicillin and incubated at 30°C, 250 rpm, until the cell density reached an optical density (OD 600) of 0.4. Isopropyl-␤-D-thiogalactoside (IPTG; Fisher Biotech) was added to a final concentration of 0.5 mM, and cells were incubated at 30°C, 250 rpm, for 4 h. Cells were collected and stored at Ϫ20°C for lipid extraction.
Q measurements: electrochemical and UV detection. A known amount of the internal standard Q 6 was added to all samples and calibration curve standards before lipid extraction. The same amount of Q 6 was also added to the Q9 and Q10 standards prepared at different concentrations to generate an extracted standard curve. Lipid extractions were then performed on Q 9 and Q10 standards, mouse tissue homogenates, and E. coli cell pellets by using a standard method. Each sample or standard was mixed with 0.5 ml of water, 9 ml of methanol, and 6 ml of petroleum ether. The mixtures were vortexed for 1 min and centrifuged at 910 g, and the top layer of petroleum ether was removed and transferred to a separate vial. Fresh petroleum ether (6 ml) was added to the remaining aqueous phase and vortexed for 1 min. The vials were subjected to centrifugation as before, and the second petroleum ether layer was removed. The process was repeated once more, and the combined upper organic phase was dried under N 2 and resuspended in 200 l of methanol. The quinones were then separated and quantified by reverse-phase (RP)-HPLC connected to an electrochemical detector as described previously (15), with the following exceptions: the precolumn electrode was set at ϩ650 mV to oxidize all hydroquinones, and a Gilson 118 UV/Vis detector was utilized to detect quinones (275 nm) as they eluted from the column. The amounts of Q9 and Q10 in the standards and samples were calculated via the calibration curve.
Q measurements: RP-HPLC-multiple reaction monitoring. Samples and standards were extracted as described above, except with 0.05 ml of water, 0.9 ml of methanol, and 0.6 ml of petroleum ether. Samples were resuspended in 200 l of ethanol. Rhodoquinone-9 (RQ9) isolated from Ascaris suum and rhodoquinone-10 (RQ10) isolated from Rhodospirillum rubrum were used as internal standards. RP-HPLC-multiple reaction monitoring (MS/MS) was performed on a 4000 Q Trap-Hybrid triple-quad linear ion trap analyzer (Applied Biosystems/MDS Sciex) with an autosampler (CTC Analytics/LEAP Technologies, HTC PAL; 10-l injections, 20-l loop) and a Turbo-V source with the ESI probe inserted. Reverse-phase sample separation was performed via a pentafluorophenyl propyl column (5 m, 4.6 ϫ 100 mm; Phenomenex, Torrance, CA). The mobile phase was 95:5 acetonitrile-water containing 0.1% formic acid (2 ml/min). The mass spectrometer was set to the positive ion mode with the following parameters: declustering potential, 61 V for RQ9, 91 V for Q9 and RQ10, and 126 V for Q10; entrance potential, 10 V for all quinones; collision energy, 39 V for RQ9, 37 V for Q9, 45 V for RQ10, and 51 V for Q10; and collision exit potential, 12 V for RQ9 and 10 V for Q9, RQ10, and Q10. The samples were analyzed in the multiple reaction Coprecipitation of PDSS1 and PDSS2 polypeptides. To evaluate whether PDSS2-Long-kd interacts with PDSS1, we adapted an affinity purification to isolate GST-PDSS1, GST, His-PDSS2-L, and His-PDSS2-L kd. GST-PDSS1 and GST were purified using glutathione Sepharose 4B (GE Healthcare BioSciences), and His-PDSS2-L and His-PDSS2-L kd were purified using Ni-NTA Superflow (Qiagen) according to the manufacturer's instructions. Briefly, BL21 (DE3) E. coli cells harboring pET28c-Pdss2-L, pET28c-Pdss2-L kd, pGEX-mSPS1 (39), and pGEX-KG empty vector grown in 50 ml of LB medium plus appropriate antibiotics were induced by 0.5 mM IPTG for 3 h at 30°C. After centrifugation to collect cells, the pellets were sonicated for 12 cycles of 10-s sonication and 10-s intervals on ice in buffer 1, composed of 50 mM sodium phosphate, 0.5 M sodium chloride, 5% (wt/vol) sucrose, 1% (vol/vol) glycerol, and 1% (vol/vol) Tween 20 (pH 7.0). After addition of protease inhibitors (Complete, EDTA-free; Roche), the sonicated samples were rotated gently for 1 h at 4°C. The samples were centrifuged at 18,000 g for 20 min at 4°C, and supernatants were subsequently transferred to new tubes.
To purify the GST-PDSS1 and GST polypeptides, the supernatants containing the solubilized proteins were incubated with glutathione Sepharose 4B resin for 1 h at room temperature and subjected to three washes with buffer 1. The bound proteins were subsequently eluted by 10 mM reduced glutathione in buffer 1. To purify the His-PDSS2-L and His-PDSS2-L kd, the supernatant with 10 mM imidazole was incubated with Ni-NTA Superflow resin for 1 h at room temperature, washed three times in buffer 1 containing 20 mM imidazole, and eluted in buffer 1 with 200 mM imidazole.
The purified proteins with each combination of PDSS1 and B6-and kd-isoforms of PDSS2-L were suspended in 1ϫ PBS with 0.1% Tween 20 and 5 mM MgCl 2. His-PDSS2-L B6 or His-PDSS2-L kd protein were incubated with GST-PDSS1 for 30 min and subsequently precipitated by Ni-NTA Superflow resin. A coprecipitation assay of GST and His-PDSS2-L B6 also was performed as a negative control at the same time. After the precipitation step, the resins were washed three times with 1ϫ PBS with 0.1% Tween 20, 5 mM MgCl 2, and 20 mM imidazole, and then precipitated proteins were analyzed by Western blotting.
Generation of polyclonal antisera to the PDSS2 polypeptides. Polyclonal antisera were obtained from rabbits by using a standard immunization protocol (Cocalico Biologicals, Reamstown, PA). To generate antibody against PDSS2, the pET28c-PDSS2-L plasmid expressing the full-length of PDSS2 with a 6-His tag at the NH 2 terminus was used to transform E. coli strain BL21 (DE3) (Novagen). The fusion protein was induced by 0.5 mM IPTG (Fisher Biotech) at 30°C for 3 h and purified from the bacterial lysate under denaturing conditions (8 M urea in 1ϫ PBS, adjusted to pH 7.4) by Ni-NTA Superflow resin (Qiagen). Elution fractions containing partially purified 6ϫ histidine-fused PDSS2 were concentrated by Amicon Ultra-10,000 MWCO (Millipore). These procedures were repeated until a total of 2 mg of the PDSS2 protein was recovered. The concentrated sample was subjected to SDS-PAGE on an 11% gel, 1.5 mm thick. After staining of the gel with Coomassie blue, the band corresponding to PDSS2 was excised and used as antigen. The specificity of the antisera was determined by immunoblotting with E. coli-produced PDSS2 polypeptide without any epitope tags. The antisera were affinity purified as described previously (32) . kd/kd mice appear to grow and mature normally and onset of kidney disease is variable but usually is evident no earlier than 8 wk of age (14, 34) . Given this relatively late onset of kidney disease, it is important to determine the age at which low Q levels manifest. As shown in Fig. 2 and Table 1 , the content of Q 9 and Q 10 in kidney lipid extracts of B6.Pdss2 kd/kd mice failed to increase with age, an increase that is dramatic in the B6 wild-type littermates. The content of Q 9 and Q 10 in kidney lipid extracts of B6 wild-type littermates 75 days of age or older was significantly higher compared with that of the B6.Pdss2
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Determination of Q content in kidney and
kd/kd mice. To delineate the timing of the increase in quinone content, kidneys were obtained from B6 wild-type mice at 20, 30, 40, 50, and 60 days of age, and the content of Q 9 and Q 10 were determined by RP-HPLC/MS-MS as described. As shown in Table 2 , the content of Q 9 and Q 10 was already elevated in kidney lipid extracts prepared from 40-day-old mice. Thus the B6.Pdss2 kd/kd mice develop kidney disease several weeks after the normal increase in Q 9 and Q 10 content fails to occur.
A similar trend was observed in liver, except that the increase in B6 wild-type liver Q 9 content occurred later ( Fig. 3 and Table 3 ). Hence, a lower content of liver Q 9 in the B6.Pdss2 kd/kd mice was evident only after 149 days of age. Sporadic rescue of Q content B6.Pdss2 kd/kd mutant mice by a partial Pdss2 transgene. The BAC clone 256E1 contains exons 1-5 of the Pdss2 gene (see Fig. 1B ) and was used to establish a rescued line of B6.Pdss2 kd/kd mice (line G) (34). The B6.Pdss2 kd/kd -line G mice were the only one of 13 transgenic lines generated that expressed the Pdss2 transgene at a high level. Mouse kidney lipid extracts prepared from B6.Pdss2 kd/kd and B6.Pdss2 kd/kd -line G transgenic mice were analyzed for Q 9 and Q 10 content as described in Fig. 2 . Remarkably, rescue of Q content in the line G mice was sporadic. Intriguingly, a low content of Q 9 and Q 10 in the transgene-positive mice was found to correlate with elevated levels of albumin in the urine (Fig. 4 and Table 4 ).
Functional analysis of PDSS2-Long, PDSS2-LongV177M, and PDSS2-Short isoforms of prenyl diphosphate synthase.
Prenyl diphosphate synthase activity has been shown to require both PDSS1 and PDSS2 subunits (39) . The plasmid construct pM12L allowed for coexpression of mouse PDSS1 and PDSS2-Long in E. coli (Fig. 5A) . Transformation of an ispB prenyl diphosphate synthase mutant (E. coli strain KO229) with this construct rescued aerobic growth and converted the quinone synthesized in E. coli cells from Q 8 to Q 9 ( Fig. 5B and Table 5 ) (39) . Coexpression of PDSS1 and PDSS2-Long-V117M (from plasmid pM12Lkd) failed to rescue the E. coli ispB mutant (data not shown). However, transformation of kd/kd mice than in B6 wild-type mice. Wild-type B6, heterozygous B6.ϩ/kd, and mutant B6.Pdss2 kd/kd mice were killed at the ages shown, and Q levels were measured in kidney homogenates prepared from each mouse. Error bars indicate the standard deviation in 3 separate measurements of the same lipid extract. Levels of Q9 and Q10 in 123-and 151-day-old B6.Pdss2 kd/kd mice and in 115-and 149-day-old B6 mice were previously reported (33).
wild-type DH5␣ E. coli with pM12Lkd allowed for the expression of Q 9 in addition to Q 8 . E. coli DH5␣ harboring either empty vector (pGEX-KG) or pM12S (directing coexpression of PDSS1 and PDSS2-Short) failed to generate appreciable levels of Q 9 , indicating that the PDSS2-Short form fails to support prenyl diphosphate synthase activity. The Q 9 content in DH5␣ E. coli cells harboring pM12Lkd (34.8 Ϯ 7.6 pmol Q 9 /mg wet weight cell pellet) was significantly lower than in cells harboring pM12L (93.7 Ϯ 6.0 pmol Q 9 /mg wet weight cell pellet). These results indicate that heterologous expression of the kd mutant form of PDSS2 in E. coli recapitulates the deficiency observed in the B6.Pdss2 kd/kd mice. Capture of GST-tagged PDSS1 coprecipitated PDSS2-Long and PDSS2-Long-kd (Fig. 6) . Thus the V117M mutation in domain I of PDSS2-Long-kd does not prevent its association with PDSS1.
Steady-state polypeptide levels of PDSS2-Long and PDSS2-Short were examined in liver mitochondria isolated from B6 wild-type, B6.Pdss2 kd/kd , and B6.Alb/cre,Pdss2 loxP/loxP mice. Both PDSS2-Long and PDSS2-Short polypeptides were readily detected in liver mitochondria isolated from B6 wildtype mice (Fig. 7) . Steady-state levels of both polypeptides were lower in the liver mitochondria of B6.Pdss2 kd/kd mice, suggesting that the lower Q 9 and Q 10 content in liver of the B6.Pdss2 kd/kd mice may result from a combination of impaired polyprenyl diphosphate activity and lower steady-state levels of the PDSS2 polypeptide. Only small amounts of the PDSS2-Long polypeptide were detectable in liver mitochondria isolated from B6.Alb/cre,Pdss2 loxP/loxP mice, where the Pdss2 gene is knocked out in hepatocytes (33) . A drastic decrease in liver Q 9 content was evident in these mice; the content of Q 9 measured in two different animals (95 days old) using the RP-HPLC-MS/MS assay (see MATERIALS AND METHODS) was 8.9 Ϯ 2.4 and 33.5 Ϯ 6.7 pmol Q 9 /mg liver protein, whereas normal Q 9 content in age matched controls was ϳ10 times higher.
Rescue of renal disease by Q 10 supplementation. In a pilot experiment, three male and two female B6.Pdss2 kd/kd mice were supplemented with 0.25 mg Q 10 /ml drinking water and compared with their untreated littermates. When the mice were tested at 132 days of age, the mutants had less urine albumin than their untreated littermates (7.2 Ϯ 5.8 vs. 13.5 Ϯ 8.3 mg/24 h, respectively). However, this difference was not significant as indicated by Student's t-test (P ϭ 0.288). Therefore, beginning at weaning, the offspring produced by the B6.Pdss2 kd/kd -sup- Values are means Ϯ SD at indicated ages.
plemented mice received double the dose (0.50 mg Q 10 /ml drinking water), equivalent to ϳ200 mg Q 10 ⅐kg body wt Ϫ1 ⅐day Ϫ1 (see MATERIALS AND METHODS). After mice reached at least 130 days of age, urine albumin was determined. Supplemented mice had on average a fivefold reduction in the urine albumin content compared with unsupplemented, agematched B6.Pdss2 kd/kd mice, and their nephritis scores were significantly lower (P ϭ 0.004, Student's t-test) than those of untreated B6.Pdss2 kd/kd controls (Table 6 ). However, the content of Q 9 and Q 10 of supplemented animals (n ϭ 7; 267.2 Ϯ 86.7 pmol Q 9 /mg kidney protein and 37.1 Ϯ 16.1 pmol Q 10 /mg kidney protein) was not significantly different from the content in the untreated B6.Pdss2 kd/kd controls (n ϭ 3; 353.0 Ϯ 40.5 pmol Q 9 /mg kidney protein and 45.2 Ϯ 6.0 pmol Q 10 /mg kidney protein). Doubling the dose to 400 mg ⅐ kg body wt Ϫ1 ⅐ day Ϫ1 did not improve the effectiveness of the treatment (Table 6 ). Examples of H&E-stained sections from the kidneys of Q 10 -treated and untreated Pdss2 kd/kd mice are shown in Fig. 8, A and B, respectively. 
DISCUSSION
Mice harboring the homozygous kd/kd mutation in Pdss2 show normal growth and fertility but develop kidney disease as young adults. Severe tubulointerstitial nephritis and tubular dilation are accompanied by morphological disorders of mitochondria in kidney and liver (34) . The kd/kd mutation (V117M) occurs within the conserved domain I of PDSS2 (Fig. 1A) . A decreased Q content was observed in adult B6.Pdss2
kd/kd mice (33) . In this study we inserted in frame after the carboxyl terminus of GST (GST-PDSS1) and Pdss2-S (Short form) inserted in frame after a six-Histidine tag (His6-PDSS2-S). pM12L expresses GST-PDSS1 and His6-PDSS2-L (Long form). pM12Lkd expresses GST-PDSS1 and His6-PDSS2-L-V117M (Long form harboring the kd mutation). B, BamHI; E, EcoRI; S, SalI, and Xb, XbaI. An asterisk shows the kd/kd mutation position V117M, and "rbs" indicates a ribosomal binding site from pET-28c to allow polycistronic expression of the mouse polypeptides. B: Q8, normally produced in E. coli, and Q9, generated by the heterologous expression of PDSS1 and PDSS2, were measured in lipid extracts prepared from E. coli DH5␣ harboring each of the constructs designated in A. E. coli strain KO229 harboring a deletion of the ispB prenyl diphosphate synthase gene was rescued by pM12L. Error bars indicate the standard deviation in 3 separate measurements of the same lipid extract. kd/kd mice. The normal increase at 30 -40 days of age may reflect unidentified physiological changes that occur at weaning, which normally occurs soon after day 20. The failure to increase the content of Q in kidneys of the B6.Pdss2 kd/kd mutant mice at 40 days of age precedes by at least several weeks the renal disease that develops at about 8 -10 wk of age. In contrast, Q content in liver from B6.Pdss2 kd/kd mice remains similar to wild-type mice until later in adulthood (ϳ150 days of age). This profound deficiency in Q content in the kidney early in life is likely responsible for the renal disease phenotype.
Mice express two polypeptide isoforms of PDSS2 due to alternative splicing, PDSS2-Long (exons 1-8) and PDSS2-Short (exons 1-3b) (Fig. 1B) (34) . Previous work has shown that PDSS2 forms a heterotetramer with PDSS1 and that both PDSS1 and PDSS2-Long are required for polyprenyl diphosphate synthesis (39) . In this study we have shown that coexpression of the short isoform of PDSS2 with PDSS1 in E. coli fails to reconstitute synthesis of Q 9 . We hypothesize that the PDSS2-Short form may repress nonaprenyl diphosphate synthase activity by forming an unproductive complex with PDSS1. E. coli harboring a construct coexpressing PDSS1 and PDSS2-Long-V117M (the kd mutant form) had significantly lower Q 9 content than did cells expressing PDSS1 and PDSS2-Long (wild type). These results recapitulate the low Q content observed in the B6.Pdss2 kd/kd mice and suggest that the V117M mutation in Pdss2 occurs in a conserved domain of polyprenyl diphosphate synthase and partially impairs synthesis of nonaprenyl and decaprenyl diphosphate. The mutation may affect enzymatic activity and/or heterotetramer formation. Values are means Ϯ SD. However, capture of PDSS1 coprecipitates the PDSS2-Long-V117M polypeptide, suggesting that the V117M mutation does not prevent interaction of the two subunits. Given that the short form of PDSS2 (exons 1-3b) failed to restore Q biosynthesis, it is curious that the BAC clone 256E1, which contains only a segment of the Pdss2 gene, established a rescued line of B6.Pdss2 kd/kd mice (line G) (34) . However, this clone includes exons 1-5 and in most cases rescued both kidney disease and Q levels. Remarkably, rescue of kidney disease and Q content in line G mice was sporadic. Intriguingly, a low Q content in transgene-positive mice was found to correlate exactly with elevated levels of protein in urine.
The data suggest that the renal disease phenotypes in Pdss2 kd/kd homozygous mice are caused by a decreased content of Q in the kidney. The renal disease could result from either inadequate respiratory function due to low levels of Q or increased oxidative stress because QH 2 is a potent antioxidant. The partial rescue by dietary supplementation with Q 10 is consistent with both ideas. Several lines of evidence suggest that Q/QH 2 is serving a crucial antioxidant role. Conditional knockout mice with deletions of Pdss2 in the glomerular podocytes (B6.Podocin/cre,Pdss2 loxP/loxP ) fully recapitulate the kd/kd phenotype (33) . However, kidney disease does not develop in the B6.PEPCK/cre,Pdss2 loxP/loxP mice, in which Pdss2 is deleted in renal tubular epithelial cells. Podocytes are not thought to have an energetic requirement as high as that of renal tubular epithelium, supporting the hypothesis that susceptibility to oxidative damage is the critical factor in the Pdss2 kd/kd model of kidney disease. The kidney content of Q 10 was not enhanced by supplementation with Q 10 , a finding consistent with other similar Q 10 supplementation studies (21) . However, longer periods of supplementation (e.g., 17 mo) do elevate both Q 9 and Q 10 kidney content (43) . It is well established that short-term supplementation does impact levels of Q 10 in the liver and blood plasma (24) . Hence, it seems likely that the benefits of Q 10 supplementation may be exerted on the podocytes via their filtration of blood plasma components (46) . Although in this study we have not evaluated oxidative stress or antioxidant status, other evidence that the Pdss2 kd/kd mice may be subject to oxidative stress is the finding that their susceptibility to renal disease is markedly diminished by either dietary restriction or a germ-free environment (13) . Dietary restriction is associated with decreased oxidative stress (48) and has been shown to decrease lipid peroxidation products and apoptosis in aged rat kidneys (22) . Similarly, mice reared in a germ-free environment recapitulate many aspects of dietrestricted animals and show enhanced AMP-activated protein kinase activity (1), a hallmark of the response to dietary restriction in yeast and worms (5) .
It is possible that renal disease in Pdss2 kd/kd mice results from a defect in an isoprenylated product other than Q. The PDSS2 polypeptide produces nona-and decaprenyl diphosphate, and studies of mevalonate labeling of mice and rats suggest these long-chain prenyl groups may be utilized in kidney protein prenylation (6, 31) , similar to the better characterized protein posttranslational modification with farnesyl or geranylgeranyl groups (20) . However, the fact that disease susceptibility is ameliorated by Q 10 supplementation suggests that Q itself is the most essential substrate with regard to this phenotype. Patients with mutations in the COQ2 gene show renal disease with collapsing glomerulopathy (2, 9), further indicating the causative role is a deficiency in Q itself.
Several human Q 10 -deficient patients have responded dramatically to Q 10 supplementation (36 -38, 41) . If their response is primarily based on the antioxidant function of Q 10 rather than its role in mitochondrial respiration, then antioxidants that are more readily taken up by the target tissues could be more effective therapies than Q supplementation. Experiments are in progress to determine whether other antioxidants may be more effective than Q 10 in preventing kidney disease in Pdss2 kd/kd mice.
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